AstraZeneca COVID-19 Vaccine It is “safe and effective” and should continue to be used by the European Medicines Agency Announce today after revision Concerns about blood clotting.
But the agency said it could not rule out a link between two rare cases of blood clotting in 25 people who received the vaccine. She added that the warnings should be included with information about the vaccine Provided to doctors And sick. Nine of these people died.
The European Union’s Pharmacovigilance Risk Assessment Committee (PRAC) has been asked to review the safety of the AstraZeneca vaccine after Over 20 European countries – including Germany, France, Italy, and Spain – Discontinued vaccinations Yet reports of rare coagulation disorders.
EMA Executive Director Imer Cook said in a press release that the committee had found an overall decrease in the incidence of blood clots, compared to the general population, in the nearly 20 million people who had so far given the vaccine worldwide.
“The committee has reached a clear scientific conclusion,” she said. “This is a safe and effective vaccine.”
But Sabine Strauss, Chair of PRAC, said the experts were unable to rule out a link to the 18 cases of the so-called case Thrombosis of the cerebral venous sinuses (CVST) and seven cases of Disseminated intravascular coagulation (Dubai Internet City), both are seen with low platelet count. In CVST, clots can prevent blood from draining from the brain, causing bleeding. DIC is a condition in which clots form in many tiny blood vessels throughout the body, which can lead to severe organ damage.
The EMA will continue to investigate these incidents and potential links to the vaccine. But Cook stressed that the benefits of the AstraZeneca vaccine in protecting people from COVID-19, which is currently killing thousands of Europeans every week, far outweigh any risk of clotting.
“What the committee recommended for that is to raise awareness,” she said.
Some experts had speculated that the clotting incidents were related to certain batches of the vaccine, but Strauss said the EMA did not support this theory. “PRAC did not find any evidence of a quality or a batch problem,” she said.
On Friday, reports say, the Biden administration Will be announced It will ship 2.5 million doses of AstraZeneca to Mexico and 1.5 million doses to Canada. The footage will be from current domestic supplies awaiting FDA approval, which could come as soon as next month after a large US trial of a vaccine has ended.
This move followed Request doses From Mexico earlier this week. Biden told reporters on Thursday that the United States is discussing shipping any overdoses abroad once local vaccination is complete. A senior Food and Drug Administration official, Peter Marks, testified in Congress on Wednesday that his agency has some concern about exporting so many overdoses only if vaccine immunity is proven to be short-lived and that booster doses are needed for the US population.
Others have speculated whether the AstraZeneca vaccine will create more problems in the United States, as anti-vaccination activists have taken advantage of the problems in launching it.
“Does it really have a good place to fill it? Can it be trusted enough? Or would it just be another headache?” John Moore, a virologist at Weill Cornell Medical College in New York who is developing the vaccine, told BuzzFeed News earlier in the day. this week.